Debiopharm & BIOASTER join forces to expand research to combat infectious diseases. Debiopharm and BIOASTER  announced having officialized a broad research agreement for the development of diagnostic and management innovation for infectious diseases. This relationship will harness BIOASTER’s scientific and technical expertise, including technology platforms, to support Debiopharm’s breakthrough research...

BIOASTER announced the signature of a collaboration agreement with Pherecydes Pharma, a French Biotechnology company, with the objective of discovering lytic bacteriophages, to be developed...